Global Influenza Treatment Market 2020-2030 by Product Type, Influenza Type, Administration Route, Distribution Channel, and Region: Trend Forecast and Growth Opportunity

August 2020 | 156 pages | ID: GC5AA0CAA486EN
GMD Research

Abstracts

Global influenza treatment market will reach $1,371.0 billion by 2030, growing by 3.8% annually over 2020-2030 driven by rising incidences of influenza, growing awareness and need for new drugs and treatment across the globe.

Highlighted with 83 tables and 77 figures, this 156-page report “Global Influenza Treatment Market 2020-2030 by Product Type, Influenza Type, Administration Route, Distribution Channel, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global influenza treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global influenza treatment market in every aspect of the classification from perspectives of Product Type, Influenza Type, Administration Route, Distribution Channel, and Region.

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Oseltamivir Phosphate
• Baloxavir Marboxil
• Peramivir
• Zanamivir
• Other Drugs

Based on Influenza Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Influenza A
• Influenza B
• Influenza C

Based on Administration Route, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Oral Administration
• Other Administration Routes

Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Retail Pharmacy
• Hospital Pharmacy
• Clinics
• Online Stores

Geographically, the following regions together with the listed national/local markets are fully investigated:

• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
• North America (U.S., Canada, and Mexico)
• South America (Brazil, Chile, Argentina, Rest of South America)
• RoW (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product Type, Administration Route, and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in global influenza treatment market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
AstraZeneca Plc
BioCryst Pharmaceuticals Inc.
Biondvax
Daiichi Sankyo Company
F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.)
GlaxoSmithKline Plc
Mylan N.V
Natco Pharma Limited
Novartis AG
Sanofi
Seqirus
Teva Pharmaceutical Industries Limited

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY PRODUCT TYPE

3.1 Market Overview by Product Type
3.2 Oseltamivir Phosphate
3.3 Baloxavir Marboxil
3.4 Peramivir
3.5 Zanamivir
3.6 Other Drugs

4 SEGMENTATION OF GLOBAL MARKET BY INFLUENZA TYPE

4.1 Market Overview by Influenza Type
4.2 Influenza A
4.3 Influenza B
4.4 Influenza C

5 SEGMENTATION OF GLOBAL MARKET BY ADMINISTRATION ROUTE

5.1 Market Overview by Administration Route
5.2 Oral Administration
5.3 Other Administration Routes

6 SEGMENTATION OF GLOBAL MARKET BY DISTRIBUTION CHANNEL

6.1 Market Overview by Distribution Channel
6.2 Retail Pharmacy
6.3 Hospital Pharmacy
6.4 Clinics
6.5 Online Stores

7 SEGMENTATION OF GLOBAL MARKET BY REGION

7.1 Geographic Market Overview 2019-2030
7.2 North America Market 2019-2030 by Country
  7.2.1 Overview of North America Market
  7.2.2 U.S.
  7.2.3 Canada
  7.2.4 Mexico
7.3 European Market 2019-2030 by Country
  7.3.1 Overview of European Market
  7.3.2 Germany
  7.3.3 UK
  7.3.4 France
  7.3.5 Spain
  7.3.6 Italy
  7.3.7 Russia
  7.3.8 Rest of European Market
7.4 Asia-Pacific Market 2019-2030 by Country
  7.4.1 Overview of Asia-Pacific Market
  7.4.2 Japan
  7.4.3 China
  7.4.4 Australia
  7.4.5 India
  7.4.6 South Korea
  7.4.7 Rest of APAC Region
7.5 South America Market 2019-2030 by Country
  7.5.1 Argentina
  7.5.2 Brazil
  7.5.3 Chile
  7.5.4 Rest of South America Market
7.6 MEA Market 2019-2030 by Country
  7.6.1 UAE
  7.6.2 Saudi Arabia
  7.6.3 South Africa
  7.6.4 Other National Markets

8 COMPETITIVE LANDSCAPE

8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
AstraZeneca Plc
BioCryst Pharmaceuticals Inc.
Biondvax
Daiichi Sankyo Company
F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.)
GlaxoSmithKline Plc
Mylan N.V
Natco Pharma Limited
Novartis AG
Sanofi
Seqirus
Teva Pharmaceutical Industries Limited

9 INVESTING IN GLOBAL MARKET: RISK ASSESSMENT AND MANAGEMENT

9.1 Risk Evaluation of Global Market
9.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Global Influenza Treatment Market, 2019-2030
Table 2. Main Product Trends and Market Opportunities in Global Influenza Treatment Market
Table 3. Global Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 4. Global Influenza Treatment Market by Influenza Type, 2019-2030, $ mn
Table 5. Global Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 6. Global Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 7. Global Influenza Treatment Market by Region, 2019-2030, $ mn
Table 8. Total Health Expenditure per capita in PPP International U.S. Dollars by Country
Table 9. Leading National Influenza Treatment Market, 2019 and 2030, $ mn
Table 10. North America Influenza Treatment Market by Country, 2019-2030, $ mn
Table 11. U.S. Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 12. U.S. Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 13. U.S. Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 14. Canada Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 15. Canada Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 16. Canada Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 17. Mexico Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 18. Mexico Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 19. Mexico Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 20. Europe Influenza Treatment Market by Country, 2019-2030, $ mn
Table 21. Germany Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 22. Germany Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 23. Germany Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 24. UK Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 25. UK Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 26. UK Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 27. France Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 28. France Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 29. France Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 30. Spain Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 31. Spain Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 32. Spain Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 33. Italy Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 34. Italy Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 35. Italy Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 36. Russia Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 37. Russia Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 38. Russia Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 39. Influenza Treatment Market in Rest of Europe by Country, 2019-2030, $ mn
Table 40. APAC Influenza Treatment Market by Country, 2019-2030, $ mn
Table 41. Japan Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 42. Japan Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 43. Japan Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 44. China Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 45. China Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 46. China Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 47. Australia Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 48. Australia Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 49. Australia Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 50. India Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 51. India Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 52. India Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 53. South Korea Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 54. South Korea Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 55. South Korea Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 56. Influenza Treatment Market in Rest of APAC by Country, 2019-2030, $ mn
Table 57. South America Influenza Treatment Market by Country, 2019-2030, $ mn
Table 58. Argentina Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 59. Argentina Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 60. Argentina Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 61. Brazil Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 62. Brazil Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 63. Brazil Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 64. Chile Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 65. Chile Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 66. Chile Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 67. MEA Influenza Treatment Market by Country, 2019-2030, $ mn
Table 68. UAE Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 69. UAE Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 70. UAE Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 71. Saudi Arabia Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 72. Saudi Arabia Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 73. Saudi Arabia Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 74. South Africa Influenza Treatment Market by Product Type, 2019-2030, $ mn
Table 75. South Africa Influenza Treatment Market by Administration Route, 2019-2030, $ mn
Table 76. South Africa Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn
Table 77. AstraZeneca Plc: Company Snapshot
Table 78. AstraZeneca Plc: Business Segmentation
Table 79. AstraZeneca Plc: Product Portfolio
Table 80. AstraZeneca Plc: Revenue, 2016-2018, $ mn
Table 81. AstraZeneca Plc: Recent Developments
Table 82. Risk Evaluation for Investing in Global Market, 2019-2030
Table 83. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 5. Global Influenza Treatment Market, 2019-2030, $ mn
Figure 6. Impact of COVID-19 on Business
Figure 7. Primary Drivers and Impact Factors of Global Influenza Treatment Market
Figure 8. GDP per capita in the World, 1960-2018, $ thousand
Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million
Figure 10. Primary Restraints and Impact Factors of Global Influenza Treatment Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Global Influenza Treatment Market
Figure 13. Breakdown of Global Influenza Treatment Market by Product Type, 2019-2030, % of Revenue
Figure 14. Global Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%)
Figure 15. Global Influenza Treatment Market: Oseltamivir Phosphate, 2019-2030, $ mn
Figure 16. Global Influenza Treatment Market: Baloxavir Marboxil, 2019-2030, $ mn
Figure 17. Global Influenza Treatment Market: Peramivir, 2019-2030, $ mn
Figure 18. Global Influenza Treatment Market: Zanamivir, 2019-2030, $ mn
Figure 19. Global Influenza Treatment Market: Other Drugs, 2019-2030, $ mn
Figure 20. Breakdown of Global Influenza Treatment Market by Influenza Type, 2019-2030, % of Sales Revenue
Figure 21. Global Addressable Market Cap in 2020-2030 by Influenza Type, Value ($ mn) and Share (%)
Figure 22. Global Influenza Treatment Market: Influenza A, 2019-2030, $ mn
Figure 23. Global Influenza Treatment Market: Influenza B, 2019-2030, $ mn
Figure 24. Global Influenza Treatment Market: Influenza C, 2019-2030, $ mn
Figure 25. Breakdown of Global Influenza Treatment Market by Administration Route, 2019-2030, % of Sales Revenue
Figure 26. Global Addressable Market Cap in 2020-2030 by Administration Route, Value ($ mn) and Share (%)
Figure 27. Global Influenza Treatment Market: Oral Administration, 2019-2030, $ mn
Figure 28. Global Influenza Treatment Market: Other Administration Routes, 2019-2030, $ mn
Figure 29. Breakdown of Global Influenza Treatment Market by Distribution Channel, 2019-2030, % of Revenue
Figure 30. Global Addressable Market Cap in 2020-2030 by Distribution Channel, Value ($ mn) and Share (%)
Figure 31. Global Influenza Treatment Market: Retail Pharmacy, 2019-2030, $ mn
Figure 32. Global Influenza Treatment Market: Hospital Pharmacy, 2019-2030, $ mn
Figure 33. Global Influenza Treatment Market: Clinics, 2019-2030, $ mn
Figure 34. Global Influenza Treatment Market: Online Stores, 2019-2030, $ mn
Figure 35. Global Market Snapshot by Region
Figure 36. Geographic Spread of Worldwide Influenza Treatment Market, 2019-2030, % of Sales Revenue
Figure 37. Global Addressable Market Cap in 2020-2030 by Region, Value ($ mn) and Share (%)
Figure 38. Health Spending as a Share of GDP by Country, 2015 and 2030
Figure 39. North American Influenza Treatment Market, 2019-2030, $ mn
Figure 40. Breakdown of North America Influenza Treatment Market by Country, 2019 and 2030, % of Revenue
Figure 41. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 42. U.S. Influenza Treatment Market, 2019-2030, $ mn
Figure 43. Canada Influenza Treatment Market, 2019-2030, $ mn
Figure 44. Influenza Treatment Market in Mexico, 2015-2030, $ mn
Figure 45. European Influenza Treatment Market, 2019-2030, $ mn
Figure 46. Breakdown of European Influenza Treatment Market by Country, 2019 and 2030, % of Revenue
Figure 47. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 48. Influenza Treatment Market in Germany, 2019-2030, $ mn
Figure 49. Influenza Treatment Market in UK, 2019-2030, $ mn
Figure 50. Influenza Treatment Market in France, 2019-2030, $ mn
Figure 51. Influenza Treatment Market in Spain, 2019-2030, $ mn
Figure 52. Influenza Treatment Market in Italy, 2019-2030, $ mn
Figure 53. Influenza Treatment Market in Russia, 2019-2030, $ mn
Figure 54. Influenza Treatment Market in Rest of Europe, 2019-2030, $ mn
Figure 55. Asia-Pacific Influenza Treatment Market, 2019-2030, $ mn
Figure 56. Breakdown of APAC Influenza Treatment Market by Country, 2019 and 2030, % of Revenue
Figure 57. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 58. Influenza Treatment Market in Japan, 2019-2030, $ mn
Figure 59. Influenza Treatment Market in China, 2019-2030, $ mn
Figure 60. Influenza Treatment Market in Australia, 2019-2030, $ mn
Figure 61. Influenza Treatment Market in India, 2019-2030, $ mn
Figure 62. Influenza Treatment Market in South Korea, 2019-2030, $ mn
Figure 63. Influenza Treatment Market in Rest of APAC, 2019-2030, $ mn
Figure 64. South America Influenza Treatment Market, 2019-2030, $ mn
Figure 65. Breakdown of South America Influenza Treatment Market by Country, 2019 and 2030, % of Revenue
Figure 66. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 67. Influenza Treatment Market in Argentina, 2019-2030, $ mn
Figure 68. Influenza Treatment Market in Brazil, 2019-2030, $ mn
Figure 69. Influenza Treatment Market in Chile, 2019-2030, $ mn
Figure 70. Influenza Treatment Market in Rest of South America, 2019-2030, $ mn
Figure 71. Influenza Treatment Market in Middle East and Africa (MEA), 2019-2030, $ mn
Figure 72. Breakdown of MEA Influenza Treatment Market by Country, 2019 and 2030, % of Revenue
Figure 73. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 74. Influenza Treatment Market in UAE, 2019-2030, $ mn
Figure 75. Influenza Treatment Market in Saudi Arabia, 2019-2030, $ mn
Figure 76. Influenza Treatment Market in South Africa, 2019-2030, $ mn
Figure 77. Growth Stage of Global Influenza Treatment Industry over the Forecast Period


COMPANIES MENTIONED

AstraZeneca Plc
BioCryst Pharmaceuticals Inc.
Biondvax
Daiichi Sankyo Company
F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.)
GlaxoSmithKline Plc
Mylan N.V
Natco Pharma Limited
Novartis AG
Sanofi
Seqirus
Teva Pharmaceutical Industries Limited